Clinical Trial

Probiotics for Diaper Dermatitis

Study acronym: ProDiaper II
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 24, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is: Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years? Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups. Participants will: * receive 6 droplets daily of probiotic or placebo for 3 weeks and * observe and record improvement of diaper rash symptoms each day using a diary.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-23.
Status change: Not Yet Recruiting → Recruiting 2025-11-21
Trial Details
NCT Number NCT06755307
Lead Sponsor University Maribor
Conditions Diaper Dermatitis
Enrollment 42 participants
Start Date 2025-08-14
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-24